首页> 外文期刊>BMC Immunology >Identification of differentially expressed circulating exosomal lncRNAs in IgA nephropathy patients
【24h】

Identification of differentially expressed circulating exosomal lncRNAs in IgA nephropathy patients

机译:IGA肾病患者差异表达循环外泌体LNCRNA的鉴定

获取原文
           

摘要

Although immunoglobulin A nephropathy (IgAN) is one of the foremost primary glomerular disease, treatment of IgAN is still in infancy. Non-invasive biomarkers are urgently needed for IgAN diagnosis. We investigate the difference in expression profiles of exosomal long non-coding-RNAs (lncRNAs) in plasma from IgAN patients compared with their healthy first-degree relatives, which may reveal novel non-invasive IgAN biomarkers. We isolated exosomes from the plasma of both IgAN patients and their healthy first-degree relatives. High-throughput RNA sequencing and real-time quantitative polymerase chain reaction (qRT-PCR) was used to validate lncRNA expression profiles. Pathway enrichment analysis was used to predict their nearest protein-coding genes. lncRNA-G21551 was significantly down-regulated in IgAN patients. Interestingly, the nearest protein-coding gene of lncRNA-G21551 was found to be encoding the low affinity receptor of the Fc segment of immunoglobulin G (FCGR3B). Exosomal lncRNA-G21551, with FCGR3B as the nearest protein-coding gene, was down-regulated in IgAN patients, indicating its potential to serve as a non-invasive biomarker for IgAN.
机译:虽然免疫球蛋白是肾病(Igan)是最重要的初级肾小球疾病之一,但Igan的治疗仍在婴儿期。 Igan诊断迫切需要无侵入性生物标志物。我们研究了Igan患者的血浆中外泌体长度非编码-RNA(LNCRNA)表达谱的差异,与其健康的一级亲属相比,这可能揭示新型无侵入性IgAn生物标志物。我们从IGAN患者的血浆和健康的一级亲属的血浆中孤立外来体。使用高通量RNA测序和实时定量聚合酶链反应(QRT-PCR)来验证LNCRNA表达谱。途径富集分析用于预测其最近的蛋白质编码基因。 LNCRNA-G21551在Igan患者中显着下调。有趣的是,发现LNCRNA-G21551的最近的蛋白质编码基因被发现编码免疫球蛋白G(FCGR3B)的Fc区段的低亲和力受体。具有Fcgr3b作为最近的蛋白质编码基因的外泌体LNCRNA-G21551在Igan患者中下调,表明其作为IgAn的非侵入性生物标志物的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号